Physical and chemical processing for a human dura mater substitute

被引:24
|
作者
Dufrane, D
Cornu, O
Delloye, C
Schneider, YJ
机构
[1] Catholic Univ Louvain, Univ Tissue Bank, Orthopaed Res Lab, B-1200 Brussels, Belgium
[2] Catholic Univ Louvain, Cell Biochem Lab, B-1348 Louvain, Belgium
关键词
dural substitute; human allograft; fascia lata; processing;
D O I
10.1016/S0142-9612(02)00027-3
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Object: Allogenic human fascia lata used in neurosurgery, as dura mater substitute, can be associated with a risk of viral and bacterial transmission. Chemical and physical procedures, developed to inactivate virus and bacteria, have been applied to fascia lata. The aim of this study consists in the evaluation of the biological properties of this treated graft. Methods: Grafts were treated with solvent detergents, freeze-dried for conservation and gamma irradiated (25,000 Gy) for sterilization. The indirect toxicity evaluation was performed by extraction method, according to the International Standard Organization (ISO). First, the cytotoxic effect of each extracts incubated in the presence of human fibroblasts (WI38) was quantitatively assessed by measuring the cell growth, the viability (succinate dehydrogenase activity, MTT), the membrane integrity (uptake of the neutral red by viable cells, NR) as well as the release of lactate dehydrogenase in the culture medium. Second, confocal laser scanning microscopy (CLSM) was used to assess the direct contact between human primary fibroblasts and graft. CLSM was performed at days 3 and 7 after cells loading. Results: No acute cytotoxicity was observed for chemically processed allografts. Cells loaded on the graft have demonstrated a good growth and spreading. Conclusions: Human fascia lata secured against conventional and non-conventional agents is a fully biocompatible alternative to the available dural graft materials. (C) 2002 Published by Elsevier Science Ltd.
引用
收藏
页码:2979 / 2988
页数:10
相关论文
共 50 条
  • [1] LYOPHILIZED HUMAN DURA MATER AS A DURAL SUBSTITUTE
    SHARKEY, PC
    USHER, FC
    ROBERTSON, RCL
    POLLARD, C
    JOURNAL OF NEUROSURGERY, 1958, 15 (02) : 192 - 198
  • [2] Clinical application of a physically and chemically processed human substitute for dura mater
    Dufrane, D
    Marchal, C
    Cornu, O
    Raftopoulos, C
    Delloye, C
    JOURNAL OF NEUROSURGERY, 2003, 98 (06) : 1198 - 1202
  • [3] NERVES OF HUMAN DURA MATER
    MARTIN, CP
    MCNAUGHTON, FL
    LI, CL
    ANATOMICAL RECORD, 1947, 97 (03): : 421 - 421
  • [4] Clinical experience with a novel bovine collagen dura mater substitute
    Costa, Bruno Silva
    Cavalcanti-Mendes, George de Albuquerque
    de Abreu, Marcelo Sartori
    de Sousa, Atos Alves
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2011, 69 (2A) : 217 - 220
  • [5] Ultrastructure of the human spinal arachnoid mater and dura mater
    Vandenabeele, F
    Creemers, J
    Lambrichts, I
    JOURNAL OF ANATOMY, 1996, 189 : 417 - 430
  • [6] Examination of the safety and efficacy of an absorbable dura mater substitute (Dura Patch®) in normal applications in neurosurgery
    von Wild, KRH
    SURGICAL NEUROLOGY, 1999, 52 (04): : 418 - 424
  • [7] Optical clearing of human dura mater
    É. A. Genina
    A. N. Bashkatov
    V. I. Kochubey
    V. V. Tuchin
    Optics and Spectroscopy, 2005, 98 : 470 - 476
  • [8] Dopamine receptors in the human dura mater
    Cavallotti, C
    Cavallotti, D
    Tonnarini, G
    Leali, FMT
    NEUROCHEMICAL RESEARCH, 2004, 29 (08) : 1499 - 1504
  • [9] Biomechanical characterization of human dura mater
    De Kegel, Dries
    Vastmans, Julie
    Fehervary, Heleen
    Depreitere, Bart
    Vander Sloten, Jos
    Famaey, Nele
    JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS, 2018, 79 : 122 - 134
  • [10] Optical clearing of human dura mater
    Genina, ÉA
    Bashkatov, AN
    Kochubey, VI
    Tuchin, VV
    OPTICS AND SPECTROSCOPY, 2005, 98 (03) : 470 - 476